effect of human recombinant thrombomodulin in sepsis

effect of human recombinant thrombomodulin in sepsis due to intestinal perforation - rTM-CHDF

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041856

Enrollment

Registered

2020-09-23

Start date

2020-09-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CHDF undergoing patients due to sepsis

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
CHDF operation periods for 4 weeks	—

Countries

Japan

Contacts

Public ContactHiroshi Kono

University of Yamanashi First Department of Surgery

hkouno@yamanashi.ac.jp+81552737390

Outcome results